Cross Country Healthcare, Inc. (CCRN)
USD 13.61
(0.59%)
USD 13.61
(0.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 337.69 Million USD | -6.48% |
| 2022 | 336.78 Million USD | 49.59% |
| 2021 | 225.14 Million USD | 20.73% |
| 2020 | 186.48 Million USD | -4.87% |
| 2019 | 196.03 Million USD | 2.1% |
| 2018 | 192.01 Million USD | -2.83% |
| 2017 | 197.6 Million USD | 4.55% |
| 2016 | 189 Million USD | 11.61% |
| 2015 | 169.34 Million USD | 14.07% |
| 2014 | 148.45 Million USD | 32.2% |
| 2013 | 112.29 Million USD | -3.68% |
| 2012 | 116.58 Million USD | -8.49% |
| 2011 | 127.4 Million USD | 5.14% |
| 2010 | 121.17 Million USD | -12.16% |
| 2009 | 137.95 Million USD | -64.87% |
| 2008 | 392.66 Million USD | 196.02% |
| 2007 | 132.64 Million USD | 6.54% |
| 2006 | 124.5 Million USD | 10.62% |
| 2005 | 112.55 Million USD | 4.24% |
| 2004 | 107.97 Million USD | -9.25% |
| 2003 | 118.98 Million USD | 15.83% |
| 2002 | 102.73 Million USD | 17.54% |
| 2001 | 87.4 Million USD | 32.88% |
| 2000 | 65.77 Million USD | -62.65% |
| 1999 | 176.12 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 79.11 Million USD | 22.58% |
| 2024 Q1 | 64.54 Million USD | -80.05% |
| 2023 Q4 | 323.54 Million USD | 336.24% |
| 2023 Q3 | 74.16 Million USD | -82.24% |
| 2023 FY | 314.95 Million USD | -6.48% |
| 2023 Q2 | 417.55 Million USD | 368.3% |
| 2023 Q1 | 89.16 Million USD | 5.73% |
| 2022 Q2 | 89.49 Million USD | 12.52% |
| 2022 FY | 336.78 Million USD | 49.59% |
| 2022 Q4 | 84.33 Million USD | 1.08% |
| 2022 Q3 | 83.43 Million USD | -6.77% |
| 2022 Q1 | 79.53 Million USD | 16.12% |
| 2021 Q2 | 52.54 Million USD | 8.16% |
| 2021 Q1 | 48.58 Million USD | 3.21% |
| 2021 FY | 225.14 Million USD | 20.73% |
| 2021 Q4 | 68.49 Million USD | 23.35% |
| 2021 Q3 | 55.52 Million USD | 5.68% |
| 2020 Q3 | 44.05 Million USD | -4.62% |
| 2020 Q2 | 46.18 Million USD | -6.09% |
| 2020 FY | 186.48 Million USD | -4.87% |
| 2020 Q4 | 47.06 Million USD | 6.85% |
| 2020 Q1 | 49.17 Million USD | -2.04% |
| 2019 FY | 196.03 Million USD | 2.1% |
| 2019 Q2 | 49.5 Million USD | 0.98% |
| 2019 Q3 | 47.31 Million USD | -4.42% |
| 2019 Q4 | 50.19 Million USD | 6.1% |
| 2019 Q1 | 49.02 Million USD | 1.61% |
| 2018 Q3 | 46.97 Million USD | -2.63% |
| 2018 Q2 | 48.24 Million USD | -0.61% |
| 2018 FY | 192.01 Million USD | -2.83% |
| 2018 Q1 | 48.54 Million USD | -1.14% |
| 2018 Q4 | 48.24 Million USD | 2.69% |
| 2017 Q1 | 49.42 Million USD | 1.91% |
| 2017 Q2 | 48.88 Million USD | -1.1% |
| 2017 FY | 197.6 Million USD | 4.55% |
| 2017 Q3 | 50.19 Million USD | 2.68% |
| 2017 Q4 | 49.1 Million USD | -2.18% |
| 2016 Q4 | 48.5 Million USD | 1.02% |
| 2016 FY | 189 Million USD | 11.61% |
| 2016 Q3 | 48.01 Million USD | 1.85% |
| 2016 Q1 | 45.34 Million USD | 7.43% |
| 2016 Q2 | 47.14 Million USD | 3.96% |
| 2015 Q4 | 42.2 Million USD | 2.54% |
| 2015 Q3 | 41.16 Million USD | -3.97% |
| 2015 FY | 169.34 Million USD | 14.07% |
| 2015 Q1 | 43.1 Million USD | -1.14% |
| 2015 Q2 | 42.86 Million USD | -0.57% |
| 2014 Q1 | 31.21 Million USD | 9.57% |
| 2014 FY | 148.45 Million USD | 32.2% |
| 2014 Q4 | 43.6 Million USD | 1.7% |
| 2014 Q3 | 42.87 Million USD | 39.35% |
| 2014 Q2 | 30.76 Million USD | -1.43% |
| 2013 Q2 | 28.2 Million USD | -1.55% |
| 2013 Q3 | 26.94 Million USD | -4.48% |
| 2013 Q4 | 28.48 Million USD | 5.73% |
| 2013 FY | 112.29 Million USD | -3.68% |
| 2013 Q1 | 28.65 Million USD | -0.26% |
| 2012 Q2 | 33.4 Million USD | -0.72% |
| 2012 Q3 | 31.86 Million USD | -4.6% |
| 2012 Q4 | 28.72 Million USD | -9.84% |
| 2012 Q1 | 33.64 Million USD | 5.49% |
| 2012 FY | 116.58 Million USD | -8.49% |
| 2011 Q4 | 31.89 Million USD | 0.96% |
| 2011 FY | 127.4 Million USD | 5.14% |
| 2011 Q2 | 32 Million USD | 0.29% |
| 2011 Q1 | 31.91 Million USD | 5.76% |
| 2011 Q3 | 31.58 Million USD | -1.31% |
| 2010 Q4 | 30.17 Million USD | 2.33% |
| 2010 Q1 | 31.21 Million USD | -2.97% |
| 2010 Q2 | 30.29 Million USD | -2.93% |
| 2010 Q3 | 29.49 Million USD | -2.66% |
| 2010 FY | 121.17 Million USD | -12.16% |
| 2009 Q4 | 32.16 Million USD | 1.81% |
| 2009 FY | 137.95 Million USD | -64.87% |
| 2009 Q1 | 37.89 Million USD | -86.79% |
| 2009 Q2 | 36.29 Million USD | -4.22% |
| 2009 Q3 | 31.59 Million USD | -12.96% |
| 2008 Q4 | 286.83 Million USD | 692.79% |
| 2008 FY | 392.66 Million USD | 196.02% |
| 2008 Q3 | 36.18 Million USD | 4.74% |
| 2008 Q2 | 34.54 Million USD | -1.61% |
| 2008 Q1 | 35.1 Million USD | 1.18% |
| 2007 Q2 | 32.29 Million USD | 0.4% |
| 2007 Q4 | 34.69 Million USD | 3.65% |
| 2007 Q1 | 32.16 Million USD | 11.97% |
| 2007 Q3 | 33.47 Million USD | 3.65% |
| 2007 FY | 132.64 Million USD | 6.54% |
| 2006 FY | 124.5 Million USD | 10.62% |
| 2006 Q4 | 28.72 Million USD | -23.08% |
| 2006 Q1 | 29.72 Million USD | 3.99% |
| 2006 Q2 | 28.7 Million USD | -3.42% |
| 2006 Q3 | 37.35 Million USD | 30.12% |
| 2005 Q1 | 27.41 Million USD | 61.26% |
| 2005 FY | 112.55 Million USD | 4.24% |
| 2005 Q2 | 28.17 Million USD | 2.77% |
| 2005 Q3 | 28.39 Million USD | 0.79% |
| 2005 Q4 | 28.58 Million USD | 0.67% |
| 2004 FY | 107.97 Million USD | -9.25% |
| 2004 Q2 | 30.83 Million USD | -0.55% |
| 2004 Q3 | 29.13 Million USD | -5.5% |
| 2004 Q4 | 16.99 Million USD | -41.66% |
| 2004 Q1 | 31 Million USD | 0.86% |
| 2003 Q2 | 29.21 Million USD | 8.9% |
| 2003 Q3 | 32.2 Million USD | 10.24% |
| 2003 Q4 | 30.74 Million USD | -4.55% |
| 2003 FY | 118.98 Million USD | 15.83% |
| 2003 Q1 | 26.82 Million USD | -1.31% |
| 2002 Q2 | 25.37 Million USD | 3.47% |
| 2002 Q3 | 25.21 Million USD | -0.63% |
| 2002 Q1 | 24.52 Million USD | 3.91% |
| 2002 FY | 102.73 Million USD | 17.54% |
| 2002 Q4 | 27.18 Million USD | 7.81% |
| 2001 FY | 87.4 Million USD | 32.88% |
| 2001 Q2 | 583.15 Million USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q3 | 22.77 Million USD | -96.1% |
| 2001 Q4 | 23.6 Million USD | 3.64% |
| 2000 FY | 65.77 Million USD | -62.65% |
| 1999 FY | 176.12 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | -91.859% |
| Addus HomeCare Corporation | 248.92 Million USD | -35.665% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -185.405% |
| Amedisys, Inc. | 834.47 Million USD | 59.532% |
| Astrana Health, Inc. | 112.59 Million USD | -199.917% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 42.506% |
| IMAC Holdings, Inc. | 5.02 Million USD | -6617.496% |
| biote Corp. | 98.82 Million USD | -241.709% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -859.219% |
| COMPASS Pathways plc | 136.91 Million USD | -146.64% |
| DocGo Inc. | 180.32 Million USD | -87.269% |
| The Ensign Group, Inc. | 335.39 Million USD | -0.687% |
| Healthcare Services Group, Inc. | 189.09 Million USD | -78.589% |
| InnovAge Holding Corp. | 558.25 Million USD | 39.508% |
| The Joint Corp. | 109.22 Million USD | -209.182% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 31.255% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -1751.194% |
| ModivCare Inc. | 586.89 Million USD | 42.461% |
| NewGenIvf Group Limited | 1.63 Million USD | -20497.02% |
| Option Care Health, Inc. | 666.62 Million USD | 49.343% |
| P3 Health Partners Inc. | 199.56 Million USD | -69.217% |
| P3 Health Partners Inc. | 199.56 Million USD | -69.217% |
| The Pennant Group, Inc. | 88.99 Million USD | -279.456% |
| Surgery Partners, Inc. | 319.5 Million USD | -5.695% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -7754.334% |
| Talkspace, Inc. | 97.58 Million USD | -246.04% |
| Talkspace, Inc. | 97.58 Million USD | -246.04% |
| The Oncology Institute, Inc. | 136.59 Million USD | -147.232% |
| The Oncology Institute, Inc. | 136.59 Million USD | -147.232% |